Indian pharmaceutical giant Dr Reddy’s Laboratories is gearing up to introduce a generic and significantly cheaper version of Novo Nordisk’s blockbuster weight-loss drug Wegovy. The company’s move ...

For the past three years, our friends and colleagues have been shrinking all around us. You probably know someone who is 'on ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

I have always loved clothes. Gaining 46kg robbed me of my sense of style, but not my interest in fashion. Nine months on GLP-1s and a diary changed everything all over again ...

Conservative commentator Scott Jennings had told a CNN panel that adding Ozempic instead of fluoride in public water systems can fix US' low birth rate ...

An India Today investigation into lax enforcement of drug norms that make accessing prescription-only medicines easy, and rising misuse of weight-loss drugs in the country ...

Medications such as Wegovy and Zepbound will no longer be covered for weight loss, although GLP-1 drugs for diabetes will still be approved.

President Donald Trump has announced the launch of TrumpRx.gov, a new federal platform designed to provide Americans with ...

The Trump administration's new discounted drug platform, TrumpRx, isn't a game-changer for consumers, health care experts ...

President Donald Trump last week launched a new prescription discount platform called TrumpRx, offering 43 medications at ...

As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to income—raising questions for both Medicaid and Medicare.